# Venoactive Drug Treatment of Pelvic Venous Disorders

> **NCT06584799** · PHASE3 · RECRUITING · sponsor: **Pirogov Russian National Research Medical University** · enrollment: 150 (estimated)

## Conditions studied

- Pelvic Venous Disorders

## Interventions

- **DRUG:** Micronized purified flavonoid fraction
- **DRUG:** Diosmin 600
- **DRUG:** Hesperidin+Diosmin combination 1000

## Key facts

- **NCT ID:** NCT06584799
- **Lead sponsor:** Pirogov Russian National Research Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12
- **Primary completion:** 2025-01
- **Final completion:** 2025-02
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2024-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06584799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06584799, "Venoactive Drug Treatment of Pelvic Venous Disorders". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT06584799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*